Travere Therapeutics, Inc. (TVTX)
63.57
+1.06
(+1.70%)
USD |
NASDAQ |
Sep 16, 12:58
Travere Therapeutics Market Cap : 5.987B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 5.887B |
| September 14, 2026 | 6.196B |
| September 11, 2026 | 6.232B |
| September 10, 2026 | 6.358B |
| September 09, 2026 | 6.236B |
| September 08, 2026 | 6.222B |
| September 04, 2026 | 6.148B |
| September 03, 2026 | 6.266B |
| September 02, 2026 | 6.331B |
| September 01, 2026 | 6.188B |
| August 31, 2026 | 6.242B |
| August 28, 2026 | 6.184B |
| August 27, 2026 | 6.359B |
| August 26, 2026 | 6.321B |
| August 25, 2026 | 6.311B |
| August 24, 2026 | 6.142B |
| August 21, 2026 | 6.188B |
| August 20, 2026 | 6.071B |
| August 19, 2026 | 6.212B |
| August 18, 2026 | 6.018B |
| August 17, 2026 | 5.983B |
| August 14, 2026 | 5.852B |
| August 13, 2026 | 5.785B |
| August 12, 2026 | 5.854B |
| August 11, 2026 | 5.670B |
| Date | Value |
|---|---|
| August 10, 2026 | 5.734B |
| August 07, 2026 | 5.775B |
| August 06, 2026 | 5.881B |
| August 05, 2026 | 5.910B |
| August 04, 2026 | 5.276B |
| August 03, 2026 | 5.178B |
| July 31, 2026 | 5.164B |
| July 30, 2026 | 5.293B |
| July 29, 2026 | 5.134B |
| July 28, 2026 | 5.166B |
| July 27, 2026 | 5.237B |
| July 24, 2026 | 5.300B |
| July 23, 2026 | 5.237B |
| July 22, 2026 | 5.199B |
| July 21, 2026 | 5.228B |
| July 20, 2026 | 5.126B |
| July 17, 2026 | 5.240B |
| July 16, 2026 | 5.108B |
| July 15, 2026 | 5.243B |
| July 14, 2026 | 5.273B |
| July 13, 2026 | 5.201B |
| July 10, 2026 | 5.229B |
| July 09, 2026 | 5.403B |
| July 08, 2026 | 5.393B |
| July 07, 2026 | 5.346B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| TG Therapeutics, Inc. | 8.585B |
| Krystal Biotech, Inc. | 10.22B |
| RenovoRx, Inc. | 75.80M |
| Pelthos Therapeutics, Inc. | 76.08M |
| ACADIA Pharmaceuticals, Inc. | 4.687B |
Market Cap Related Metrics
| PS Ratio | 10.17 |
| Price to Book Value | 244.13 |
| Price to Free Cash Flow | 390.38 |
| Price | 63.57 |
| Earnings Yield | -1.20% |